These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11520196)

  • 1. Synthesis and characterization of non-steroidal ligands for the glucocorticoid receptor: selective quinoline derivatives with prednisolone-equivalent functional activity.
    Coghlan MJ; Kym PR; Elmore SW; Wang AX; Luly JR; Wilcox D; Stashko M; Lin CW; Miner J; Tyree C; Nakane M; Jacobson P; Lane BC
    J Med Chem; 2001 Aug; 44(18):2879-85. PubMed ID: 11520196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal selective glucocorticoid modulators: the effect of C-5 alkyl substitution on the transcriptional activation/repression profile of 2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.
    Elmore SW; Coghlan MJ; Anderson DD; Pratt JK; Green BE; Wang AX; Stashko MA; Lin CW; Tyree CM; Miner JN; Jacobson PB; Wilcox DM; Lane BC
    J Med Chem; 2001 Dec; 44(25):4481-91. PubMed ID: 11728194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.
    Kym PR; Kort ME; Coghlan MJ; Moore JL; Tang R; Ratajczyk JD; Larson DP; Elmore SW; Pratt JK; Stashko MA; Falls HD; Lin CW; Nakane M; Miller L; Tyree CM; Miner JN; Jacobson PB; Wilcox DM; Nguyen P; Lane BC
    J Med Chem; 2003 Mar; 46(6):1016-30. PubMed ID: 12620078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of quinolines as selective glucocorticoid receptor agonists.
    Jaroch S; Berger M; Huwe C; Krolikiewicz K; Rehwinkel H; Schäcke H; Schmees N; Skuballa W
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5835-8. PubMed ID: 20727743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining 3D-QSAR, docking, molecular dynamics and MM/PBSA methods to predict binding modes for nonsteroidal selective modulator to glucocorticoid receptor.
    Xu Y; Zhang T; Chen M
    Bioorg Med Chem Lett; 2009 Jan; 19(2):393-6. PubMed ID: 19081253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. trans-Activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four stereoisomers.
    Lin CW; Nakane M; Stashko M; Falls D; Kuk J; Miller L; Huang R; Tyree C; Miner JN; Rosen J; Kym PR; Coghlan MJ; Carter G; Lane BC
    Mol Pharmacol; 2002 Aug; 62(2):297-303. PubMed ID: 12130681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.
    Hudson AR; Roach SL; Higuchi RI; Phillips DP; Bissonnette RP; Lamph WW; Yen J; Li Y; Adams ME; Valdez LJ; Vassar A; Cuervo C; Kallel EA; Gharbaoui CJ; Mais DE; Miner JN; Marschke KB; Rungta D; Negro-Vilar A; Zhi L
    J Med Chem; 2007 Sep; 50(19):4699-709. PubMed ID: 17705362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.
    Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1549-52. PubMed ID: 16386422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands.
    Paul-Clark MJ; Roviezzo F; Flower RJ; Cirino G; Soldato PD; Adcock IM; Perretti M
    J Immunol; 2003 Sep; 171(6):3245-52. PubMed ID: 12960354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
    Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The search for safer glucocorticoid receptor ligands.
    Rosen J; Miner JN
    Endocr Rev; 2005 May; 26(3):452-64. PubMed ID: 15814846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects.
    Coghlan MJ; Jacobson PB; Lane B; Nakane M; Lin CW; Elmore SW; Kym PR; Luly JR; Carter GW; Turner R; Tyree CM; Hu J; Elgort M; Rosen J; Miner JN
    Mol Endocrinol; 2003 May; 17(5):860-9. PubMed ID: 12586843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and radiopharmacological characterization of [11C]AL-438 as a nonsteroidal ligand for imaging brain glucocorticoid receptors.
    Wuest F; Kniess T; Bergmann R; Henry B; Pietzsch J
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4035-9. PubMed ID: 17499506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
    De Bosscher K; Beck IM; Haegeman G
    Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity.
    Ali A; Thompson CF; Balkovec JM; Graham DW; Hammond ML; Quraishi N; Tata JR; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Miller DK; Thompson CM; Zaller DM; Forrest MJ; Carballo-Jane E; Luell S
    J Med Chem; 2004 May; 47(10):2441-52. PubMed ID: 15115388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel isoxazoline derivative of prednisolone endowed with a robust anti-inflammatory profile and suitable for topical pulmonary administration.
    Ghidini E; Capelli AM; Carnini C; Cenacchi V; Marchini G; Virdis A; Italia A; Facchinetti F
    Steroids; 2015 Mar; 95():88-95. PubMed ID: 25556984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and local anti-inflammatory activity of 17β-carboxamide derivatives of glucocorticoids.
    Dobričić V; Marković B; Milenković N; Savić V; Jaćević V; Rančić N; Vladimirov S; Cudina O
    Arch Pharm (Weinheim); 2014 Nov; 347(11):786-97. PubMed ID: 25159891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a new 2-prenylated quinoline as potential drug for metabolic syndrome with pan-PPAR activity and anti-inflammatory effects.
    Villarroel-Vicente C; García A; Zibar K; Schiel MA; Ferri J; Hennuyer N; Enriz RD; Staels B; Cortes D; Cabedo N
    Bioorg Med Chem Lett; 2024 Jul; 106():129770. PubMed ID: 38677560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists.
    Akritopoulou-Zanze I; Patel JR; Hartandi K; Brenneman J; Winn M; Pratt JK; Grynfarb M; Goos-Nisson A; Von Geldern TW; Kym PR
    Bioorg Med Chem Lett; 2004 May; 14(9):2079-82. PubMed ID: 15080982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826).
    Weinstein DS; Gong H; Doweyko AM; Cunningham M; Habte S; Wang JH; Holloway DA; Burke C; Gao L; Guarino V; Carman J; Somerville JE; Shuster D; Salter-Cid L; Dodd JH; Nadler SG; Barrish JC
    J Med Chem; 2011 Oct; 54(20):7318-33. PubMed ID: 21899328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.